Neurogene (NGNE) Tax Rate (2013 - 2014)
Neurogene (NGNE) posted Tax Rate of 2.29% for Q4 2014, down 64907.8% on a QoQ basis from 0.0% in Q3 2014, and down 229.0% year-over-year from 1.77% in Q4 2013.
Neurogene (NGNE) Tax Rate (2013 - 2014) Analysis & Trends
Neurogene's Tax Rate history runs 2 years deep, the most recent figure standing at 2.29% for Q4 2014.
- Quarterly Tax Rate fell 229.0% year-over-year to 2.29% in Q4 2014, while the trailing twelve-month figure through Dec 2014 was 0.75% (changed N/A YoY) and the FY2015 annual result came in at 2.04%, down 127.0% from the prior year.
- Tax Rate was 2.29% for Q4 2014 at Neurogene, down from 0.0% in the prior quarter.
- Across five years, Tax Rate topped out at 0.15% in Q3 2013 and bottomed at 2.29% in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -2.29 |
| Dec 31, 2014 | -2.29 |
| Dec 31, 2014 | -2.29 |
| Sep 30, 2014 | 0.00 |
| Sep 30, 2014 | 0.00 |
| Sep 30, 2014 | 0.00 |
| Dec 31, 2013 | 0.00 |
| Dec 31, 2013 | 0.00 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.15 |
| Sep 30, 2013 | 0.15 |
| Sep 30, 2013 | 0.15 |